Lanfeng Biochemical Co., Ltd.
蓝丰生化
002513
Shenzhen Stock Exchange
Key Financials
Announcements
Announcement on the Expiration of the Share Reduction Plan Period for Company Shareholders and Implementation Results
Legal Opinion from Beijing Wanshang Tianqin Law Firm Regarding the 2025 Annual Shareholders' Meeting of Jiangsu Lanfeng Biochemical Co., Ltd.
Announcement of the 2025 Annual Shareholders' Meeting Resolutions
Announcement of the 34th Meeting Resolution of the 7th Board of Directors
Q1 2026 Report
Announcement on Holding the 2025 Online Performance Briefing
Progress Announcement on Providing Guarantees for Holding Subsidiaries
Announcement on the Renewal of the Company's Audit Institution for 2026
Announcement on the Confirmation of 2025 Annual Remuneration for Directors and Senior Management and the 2026 Remuneration Plan
2025 Annual Independent Director Work Report (Yuan Jian)
2025 Annual Independent Director Work Report (Tang Jian)
2025 Annual Independent Director Work Report (Liu Xingchong)
2025 Annual Internal Control Audit Report
2025 Annual Internal Control Self-evaluation Report
Articles of Association of Jiangsu Lanfeng Biochemical Co., Ltd. (April 2026)
Remuneration Management System for Directors and Senior Management (April 2026)
Announcement on Increasing Registered Capital, Amending the Articles of Association, and Handling Business Registration and Revising Corporate Governance Systems
Announcement on Changes in Accounting Policies
Announcement on the Company's Uncovered Losses Reaching One-third of the Total Paid-in Capital
Announcement on the Increase of Borrowing Limit from Controlling Shareholders by the Company and its Controlling Subsidiaries and Related Transactions
Announcement on the Application for Comprehensive Credit Limits from Financial Institutions by the Company and Subsidiaries in 2026 and Acceptance of Related Party Guarantees
Announcement on the Expected Financial Assistance Limit for Subsidiaries and Related Transactions in 2026
Feasibility Analysis Report on Conducting Derivative Trading Business in 2026
Announcement on the Expected Derivative Trading Limit for 2026
Announcement on the Expected External Guarantee Limit for Subsidiaries in 2026
Notice of the 2025 Annual Shareholders' Meeting
Resolution of the First Special Meeting of Independent Directors in 2026
Shareholder Return Plan for the Next Three Years (2026-2028)
2025 Annual Financial Settlement Report
2025 Annual Board Work Report
Notes & Comments
Sign in to leave a comment or private note.
Loading…